Clinical Trial Update: The SUGAR Study; SBRT and Relugolix) for Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Yale University is evaluating the combination of SBRT and Relugolix for prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Yale University | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING